Microbix Biosystems Inc. (TSE:MBX) Senior Officer Philip Jonathan Casselli Sells 50,000 Shares

Microbix Biosystems Inc. (TSE:MBX) Senior Officer Philip Jonathan Casselli sold 50,000 shares of the firm’s stock in a transaction on Wednesday, January 22nd. The shares were sold at an average price of C$0.42, for a total transaction of C$21,000.00.

Microbix Biosystems Trading Up 19.5 %

Microbix Biosystems stock opened at C$0.52 on Thursday. The company has a market cap of C$71.08 million, a price-to-earnings ratio of 13.00 and a beta of 0.34. The firm has a 50-day moving average of C$0.37 and a 200-day moving average of C$0.35. The company has a debt-to-equity ratio of 22.68, a current ratio of 6.62 and a quick ratio of 5.57. Microbix Biosystems Inc. has a one year low of C$0.29 and a one year high of C$0.52.

Microbix Biosystems Company Profile

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.